Obesity: New life for antidiabetic drugs.
Where this comes from
- Record sourced from PubMed, PMID 20651677.
- Also identified by DOI 10.1038/466443a and PMC identifier PMC420412.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anti-diabetic drugs that activate the protein PPARγ had a bright start but soon lost appeal due to undesirable side effects. Subtle modifications may once again make them suitable for treating diabetes.